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Background: Whole blood gene expression-based molecular diagnostic tests are becoming increasingly available.
Conventional tube-based methods for obtaining RNA from whole blood can be limited by phlebotomy, volume
requirements, and RNA stability during transport and storage. A dried blood spot matrix for collecting high-quality
RNA, called RNA Stabilizing Matrix (RSM), was evaluated against PAXgene® blood collection tubes.
Methods: Whole blood was collected from 25 individuals and subjected to 3 sample storage conditions: 18 hours
at either room temperature (baseline arm) or 37°C, and 6 days at room temperature. RNA was extracted and
assessed for integrity by Agilent Bioanalyzer, and gene expression was compared by RT-qPCR across 23 mRNAs
comprising a clinical test for obstructive coronary artery disease.
Results: RSM produced RNA of relatively high integrity across the various tested conditions (mean RIN ± 95% CI:
baseline arm, 6.92 ± 0.24; 37°C arm, 5.98 ± 0.48; 6-day arm, 6.72 ± 0.23). PAXgene samples showed comparable RNA
integrity in both baseline and 37°C arms (8.42 ± 0.17; 7.92 ± 0.1 respectively) however significant degradation was
observed in the 6-day arm (3.19 ± 1.32). Gene expression scores on RSM were highly correlated between the
baseline and 37°C and 6-day study arms (median r = 0.96, 0.95 respectively), as was the correlation to PAXgene
tubes (median r = 0.95, p < 0.001).
Conclusion: RNA obtained from RSM shows little degradation and comparable RT-qPCR performance to PAXgene
RNA for the 23 genes analyzed. Further development of this technology may provide a convenient method for
collecting, shipping, and storing RNA for gene expression assays.Background
A variety of physiological changes and disease states can
alter gene expression in peripheral blood cells. Measur-
ing the level of specific RNA species in the bloodstream
has proven to be a powerful tool for monitoring disease
occurrence and stratifying patient risk for a variety of
oncological, neurological, immunological, and cardiovas-
cular disorders [1-5].
Blood is a plentiful and highly accessible fluid that can be
sampled through minimally invasive techniques. However,
a number of physiological and environmental factors can
reduce the quality of blood samples and blood RNA when
maintained ex vivo. First, gene expression artifacts are
known to occur rapidly after phlebotomy collection unless
blood cell metabolism is immediately arrested in some
manner such as freezing or chemical lysis [6]. Second, RNA* Correspondence: kvame@ge.com; jwingrove@cardiodx.com
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unless otherwise stated.species are highly sensitive to enzymatic degradation
from ubiquitous ribonucleases (RNases) that are en-
demic to biological samples and environmental surfaces.
Lastly, RNA is chemically unstable and prone to self-
hydrolysis through trans-esterification reactions cata-
lyzed by temperature, alkaline pH, and water [7]. These
preanalytical issues have traditionally demanded that
RNA be isolated and maintained at low temperatures
immediately after blood collection.
For many research and diagnostic applications, immedi-
ate RNA purification is inconvenient or impossible, and
maintaining RNA samples at low temperatures adds sig-
nificant costs. Several liquid preservatives have been
developed to stabilize RNA immediately upon blood col-
lection and reduce dependencies on refrigeration, includ-
ing PAXgene® and TEMPUS® blood collection tubes [8,9].
However, these tube-based methods afford a limited win-
dow for RNA stabilization at ambient temperature (3 days
or 5 days at 18-25°C, respectively), require a trained. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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blood in an excess volume of liquid preservative. As a con-
sequence, tube-based collection formats are prone to poor
RNA quality if filled imperfectly or incorrectly, and are
not recommended for use in uncontrolled environments
such as field collection or standard shipping [10]. The
volumetric requirements of PAXgene and TEMPUS
(2.5 mL or 3 mL whole blood, respectively) are also not
suitable for applications involving infants and small ani-
mals [11,12]. These factors led us to test the feasibility of
developing a solid matrix for simultaneous collection and
preservation of high-quality RNA in whole blood samples,
similar to FTA® technology. FTA is a filter paper-based
product line that streamlines sample handling and nucleic
acid preservation by permitting sample collection and
stabilization steps at the point-of-collection in a substan-
tially dry state [13].
In this study, we evaluate a dried blood spot matrix opti-
mized for collecting and preserving high-quality RNA,
termed RNA Stabilizing Matrix (RSM), and compare RNA
integrity and gene expression levels relative to PAXgene
blood collection tubes drawn in parallel. Gene expression
was compared across 23 target messenger RNAs compris-
ing the Corus® CAD test, a clinically-validated test that
identifies the likelihood of obstructive coronary disease
[4,14,15]. We demonstrate that comparable results are ob-
tained between RSM filter paper and PAXgene blood col-
lection tubes under overnight sample storage conditions,
and RSM performance exceeds PAXgene results with
longer-term room temperature storage. The features of-
fered by this improved dried blood spot technology may
increase patient access and enable cost-effective sample




RSM is a filter paper-based matrix containing a propri-
etary reagent formulation for lysing blood cells and sta-
bilizing RNA. Test samples were prepared for this study
using a GE Modular Membrane Modification (GEM3)
pilot manufacturing line at GE Global Research.
Rat blood collection and dried blood spot extraction
Male Sprague–Dawley rats (180-250 g) were purchased
from Charles River Laboratories. The experimental
protocol of this study was approved by the IACUC at
General Electric Global Research (Niskayuna, NY), which
is an AAALAC, USDA, and OLAW accredited facility.
Rats were housed in standard cages (Alternative Design
Manufacturing & Supply Inc.), and throughout the study
were provided with ad libitum access to standard com-
mercial feed (Lab Diet; Purina Mills) and water. All ani-
mals were maintained on a 12-hr:12-hr light: dark cycle inrooms with controlled temperature (approximately 24°C)
and humidity (approximately 40%). Whole blood was
collected via pipette directly from a 26 gauge catheter
placed in the tail vein of anaesthetized rats. Fifty micro-
liter aliquots were transferred without anticoagulant
and spotted onto chemically-treated and untreated filter
papers. Blood spots were dried and maintained at ambi-
ent lab temperature for 11 days in a desiccator cabinet
(~20% relative humidity). Two sample discs were punch-
ed from each dried blood spot using a 7 mm Harris
Uni-Core punch (Fisher Scientific) treated with 15 μl PK
solution (4 mg/ml proteinase K +0.5%SDS) per punch.
Sample discs were transferred into a 1.5 ml microcentri-
fuge tube containing 350 μl of extraction solution (RLT
buffer with 1% β-mercaptoethanol, Qiagen) and incubated
for 20 min at 40°C on a Thermomixer (Eppendorf) at
700 rpm. After incubation, RNA was purified from 350 μl
of eluate using QIAamp RNA Blood Mini kit (Qiagen)
and eluted in 40 μl of nuclease-free water.Human blood collection and application onto RSM paper
The whole blood used in the study was collected from
donors who had granted written consent. Ethics ap-
proval for this study was obtained from the Western In-
stitutional Review Board (Protocol #20090362). Venous
blood samples were collected via phlebotomy into EDTA
or heparin coated blood tubes (Fisher Scientific). Imme-
diately after blood drawing and mixing, 50 μl of blood
was pipetted from the blood tubes and applied onto one
piece of RSM paper by dispensing in a circular motion
within the spotted circle. The samples were allowed to
dry at room temperature for ~2 hours and then placed
back into the original Mylar pouch with fresh desiccant
and stored at three different conditions: overnight
(18 hours) at room temperature (~25°C), 6 days at room
temperature or overnight (18 hours) at 37°C .Human RNA extraction from RSM paper
Four to five 6 mm sample discs were prepared from each
dried blood spot by using a 6 mm Harris Uni-Core
punch (Fisher Scientific). The sample discs were placed
on parafilm and 15 μl PK solutions (4 mg/ml proteinase
K +0.5%SDS) was added onto each disc and incubated at
room temperature for 15 minutes. Discs from 2 blood
spots were placed into 1.5 ml microcentrifuge tubes con-
taining 800 μl of extraction solution (RLT buffer with 1%
β-mercaptoethanol, Qiagen) and incubated for 30 min at
37°C on a Thermomixer (Eppendorf) at 600 rpm. After
incubation, 700 μl of eluate was transferred to a new
microcentrifuge tube and mixed with 400 μl of isopropa-
nol and 10 μl SPRI beads from the Agencourt RNAd-
vance Blood kit (Beckman Coulter Genomics). RNA was
then extracted following the manufacturer’s instruction;
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Ambion DNase I kit (Ambion) at 37°C for 10 min.
PAXgene RNA blood collection and RNA extraction
Human whole blood samples were collected in PAX-
gene® RNA Blood Tubes according to the manufacturer’s
instructions (PreAnalytix). RNA was isolated by means
of a magnetic bead based approach using a modified ver-
sion of the Agencourt RNAdvance Blood kit (Beckman
Coulter Genomics) and the Hamilton STAR automated
liquid handler (Hamilton). Extraction was performed in
96-well plates containing 400 μl of whole blood per well;
genomic DNA removal was performed using the Ambion
DNase I kit (Ambion) at 37°C for 10 min.
Internal PAX pool blood control
Approximately 2.5 mL of blood was collected in PAX-
gene® RNA Blood Vacutainer Tubes from consented do-
nors (Western IRB Protocol #20090362). The blood/
PAXgene reagent mixture from donor tubes were pooled
together. After pooling and mixing, each pool was dis-
tributed into 1.5 ml aliquots and stored at −20°C.
RNA analysis
Purified RNA was quantified by absorbance at 260 nm
using the NanoDrop 8000 (Thermo Scientific). RNA in-
tegrity was assessed by Agilent 2100 Bioanalyzer using the
Eukaryote total RNA 6000 Pico Assay kit according to the
manufacturer’s instructions (Agilent Technologies, Palo
Alto, CA). The RNA integrity numbers (RIN) were calcu-
lated using the Agilent 2100 Expert Software (RIN = 1;
lowest RNA quality to RIN = 10; highest RNA quality).
Reverse transcription
RNA was reverse-transcribed to cDNA using the High
Capacity Reverse Transcription Kit (Life Technologies).
The RNA extracted from PAXgene tubes was adjusted
to 6 ng/μl and cDNA samples diluted to a RNA equiva-
lent of 1 ng/μl for downstream processing. All available
RNA extracted from RSM paper (estimated ~200 ng) was
used in cDNA reaction without mass normalization.
RT-qPCR gene expression
The manufacture of commercial GES RT-qPCR assay
plates is described elsewhere [16]. RT-qPCR reactions
were performed by addition of 2 μL of cDNA sample
onto the GES plates. All RT-qPCR reactions were run
using the Light Cycler 480 II (Roche) using the following
cycling condition: 50°C 2 minutes, 95°C 10 minutes and
45 cycles of 95°C 15 seconds and 60°C 1 minute. Indi-
vidual Crossing point (Cp) values were calculated using
LC480 II software (Roche). Genomic DNA contamin-
ation was assessed by comparing expression values for
splice-junction spanning and intergenic TFCP2 assays.Additional data relating to MIQE criteria can be found
in Additional file 1: Table S1.
Statistical methods
All analysis was performed using R, version 2.15. Stand-
ard methods were used to estimate means, SD’s, and
correlations. Individual gene expression values were nor-
malized to HNRNPF and TFCP2; normalization within
the GES occurs at the meta-gene level through the use
of ratios and low variability genes such as HNRNPF and
TFCP2. Details regarding the derivation and validation
of the GES have previously been published [4,15]. Where
appropriate, paired or unpaired t-tests were used to
compare different processing conditions with a reference
condition. Gene expression pre-processing and score
calculations were performed as previously described [4].
Results
Initial performance assessment of RSM in small-animal
studies
We compared the performance of conventional dried
blood spot technologies [17] to RSM filter paper initially
using a rat model. Fifty microliters of tail vein blood was
spotted directly onto various filter paper matrices and
stored for 11 days at room temperature. The integrity of
total RNA extracted from RSM filter paper was com-
pared to that from FTA paper, as well as untreated
Whatman 31-ETF paper (Figure 1). RNA obtained from
FTA and 31-ETF papers had RNA Integrity Number
(RIN) scores of ≤ 3, with no visible 18S or 28S RNA
bands present (Figure 1). In contrast, RNA from RSM
paper had a RIN score of 7.5, with distinct 18S and 28S
bands observed (Figure 1).
Performance of RSM with human blood under different
storage conditions
RNA integrity, yield and Real Time-qualitative PCR (RT-
qPCR) performance were compared from human blood
samples collected on RSM filter paper and PAXgene
tubes subjected to 3 different storage conditions: a base-
line arm (18 hours at RT), 18 hours at 37°C, and 6 days
at RT (Additional file 2: Figure S1).
-RNA integrity and yield
The baseline arm of this study utilized 25 healthy sub-
jects and consisted of whole blood samples spotted on
RSM and 31-ETF paper or collected in PAXgene tubes
and stored for 18 hours at room temperature (baseline
condition, RT; ~25°C). RIN scores for the RNA obtained
from the PAXgene tubes were slightly higher than those
obtained from RSM (mean RIN ±95% CI: 7.98 ± 0.54 vs.
6.92 ± 0.24 respectively, p < 0.001; Figure 2A, Additional
file 3: Figure S2A, B); mean yields were higher from the
PAXgene tubes (6.58 ng/μl vs. 4.79 ng/μl whole blood,
Figure 1 Electropherogram of total rat RNA obtained from
dried blood spots stored for 11 days at room temperature on
various filter papers. Pico Ladder standards are shown in the left
lane. Agilent Bioanalyzer RNA Integrity Number (RIN) scores are
shown at the bottom.
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ETF paper showed significant degradation (2.87 ± 0.11;
Figures 1, 2A, Additional file 3: Figure S2C) and decreased
mean yield versus baseline (2.34 ng/μl, p < 0.001).
To understand the impact of both time and temperature
on RNA stored on RSM filter paper, RNA was extracted
from dried blood spots stored for 18 hours at 37°C and
6 days at RT. A subset of 10 samples from the baseline
arm was used for this 2-arm study (Additional file 2:
Figure S1). RNA obtained from RSM stored for 18 hours
at 37°C had slightly lower RIN scores compared to base-
line (5.98 ± 0.48 vs. 6.92 ± 0.24 respectively, p < 0.001,
Figure 2A, Additional file 3: Figure S2D) and lower
mean yield compared to baseline (4.46 ng/μl, p > 0.05)
whereas the RNA obtained from RSM stored for 6 days
at RT had RIN scores comparable to baseline samples
(6.72 ± 0.23, Figure 2A, Additional file 3: Figure S2E);
with slightly higher mean yields versus baseline (5.4 ng/μl,
p > 0.05) Paxgene RNA stored at 37°C versus room
temperature for 18 hours also showed slightly lower
RIN values (7.92 ± 0.1, 8.42 ± 0.17 respectively, p < 0.001;Figure 2B, Additional file 3: Figure S2F, G) and lower
mean yield compared to baseline (4.86 ng/μl, p < 0.001);
whereas PAXgene RNA stored for 6 days at RT displayed
significant degradation (3.19 ± 1.32, p < 0.001; Figure 2B,
Additional file 3: Figure S2H) and lower mean yield versus
baseline (5.78 ng/μl, p < 0.05).
-RT-qPCR
To evaluate the RNA isolated under the various condi-
tions with a functional test, 23 genes used in a clinically
validated, gene expression-based diagnostic test for ob-
structive coronary artery disease [4] were assayed by RT-
qPCR. Overall, only slight changes in gene expression
levels were observed from RSM paper stored at 37°C or
6 days compared to the baseline arm, with a median
delta Crossing point (Cp) of 0.15 observed for both com-
parisons (Figure 3A). Fifteen of the 23 genes tested
showed no significant difference in expression levels (Cp
values) between the 3 arms (Table 1). Two genes (CD3D,
TLR4) showed a significant shift in Cp values in the 37°C
arm whereas 7 genes (CD3D, IL18RAP, KLRC4, NCF4,
RPL28, TNFAIP6, TNFRSF10C) showed significant shifts
in the 6-day arm (Table 1), with only CD3D affected sig-
nificantly in both arms. In comparison, the median delta
Cp between the baseline arm and 37°C was slightly larger
for PAXgene samples relative to RSM (0.53 vs. 0.15 Cp re-
spectively; Figure 3A), and noticeably larger for PAXgene
when compared to the 6-day arm (1.97 vs. 0.15 Cp;
Figure 3A). Thus, for the 23 genes analyzed, mean gene
expression from RSM paper was less sensitive to elevated
temperature or prolonged storage compared to PAXgene-
stabilized RNA.
Condition-induced shifts in gene expression levels
may be uniform in magnitude and direction. To assess
this, gene expression correlations (r) were calculated
across both arms (Figure 3B, C). The majority of the
genes showed strong correlations across the conditions
evaluated. Five genes showed low correlations (r < 0.9)
in both arms (SPIB, TMC8, AF289562, HNRPF, TFCP2;
Figure 3B, C); 3 genes showed low correlations only in
the 37°C arm (RPL28, CD79B, TNFRSF10C; Figure 3A)
whereas 2 genes showed low correlation only in the 6-
day arm (KLRC4, KCNE3; Figure 3B). The genes with
lower correlations are known to have either lower ex-
pression levels that can lead to increased variability (e.g.
AF289562) or, as previously reported, have lower bio-
logical variability in their expression levels, making
them more sensitive to changes in conditions [16].
-Gene Expression Score (GES)
To assess how RSM might perform in the context of a
gene expression-based diagnostic test (Corus CAD), the
GES was calculated from the samples obtained from
different condition arms as well as from the PAXgene
Figure 2 RIN scores of RNA obtained from RSM or PAXgene samples stored under various conditions. (A) RIN scores for RNA obtained
from either 25 subjects (PAXgene Control, RT O/N) or a subset of 10 subjects (37°C O/N, RT 6D, Negative Control). Mean values ± 95% CI are
shown. ** = p < 0.001, * = p 0.002 by paired t-test. (B) RIN scores (y axis) for RNA obtained from pooled PAXgene control samples subjected to
various conditions. 10 replicates per condition were used. Mean values ± 95% CI are shown. ** = p < 0.001 by paired t-test. Dashed lines indicate
minimum acceptable RIN for downstream gene expression analysis.
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validated using whole blood stabilized in PAXgene tubes
[4,14]. Baseline arm samples collected via PAXgene tubes
showed significant GES correlations with those collected
in parallel onto RSM filter paper (r = 0.948, p < 0.001;
Figure 4A). At the gene level, 15 genes showed strong
correlations between the PAXgene and RSM methods,
with 8 displaying weaker correlations (r < 0.9; CD79B,
TNFRSF10C, SPIB, RPL28, KCNE3, AF289562, HNRNPF,
TFCP2, TMC8; Figure 4B.)
Compared to the baseline arm, no significant change
in GES were observed for RSM samples stored at 37°C
nor in the samples stored for 6 days at RT (p > 0.05).
Overall, the high correlation between RSM- and PAXgene-
derived expression indicates that RSM could feasibly beused for such a diagnostic test with minimal adjustment
to the predictive GES.Discussion
Solid, matrix-based based approaches have been success-
fully developed for the collection and storage of DNA,
most notably for FTA cards. Use of FTA cards for the
storage of RNA is most effective with cold temperature
storage [17]. As such, we have developed and evaluated
RSM, a matrix-based platform designed specifically for
the collection and storage of RNA in whole blood at am-
bient temperature. Similar to previous findings with FTA
cards, RNA is passively eluted from RSM by rehydration
of the dried blood spot [17].
Figure 3 Delta Cps and Pearson correlation values (r) obtained
by comparing expression levels of 23 genes in the baseline
arm (RT O/N) versus 37°C O/N and RT 6D arms. (A) The delta Cp
for each gene, by condition, is shown on the Y axis; genes are
shown on the X axis. Black • = PAXgene, 37 C; Red ■ = RSM, 37 C;
Green ♦ = PAXgene, 6 days; Blue ▲ = RSM, 6 day. Horizontal lines
represent the median delta Cp of all genes for each condition;
colors of lines are same as above. (B) Pearson correlation values (r)
derived by comparing RT O/N to 37°C O/N (y axis) vs. Cp values (x
axis) for RSM; dashed line denotes r value of 0.9 (C) Pearson
correlation values (r) derived by comparing RT O/N to RT 6D (y axis)
vs. Cp values (x axis) for RSM; dashed line denotes r value of 0.9.
Table 1 Time and temperature induced changes in the
expression levels of 23 genes relative to the baseline
condition
Baseline vs. 37°C Baseline vs. 6 Day
Gene Estimate 95% CI P* Estimate 95% CI P*
AF289562 −0.371 0.739 0.285 −0.193 0.692 0.537
AQP9 0.044 0.065 0.159 −0.061 0.076 0.102
CASP5 −0.047 0.088 0.259 0.022 0.138 0.728
CD3D −0.068 0.051 0.015 0.087 0.067 0.017
CD79B −0.050 0.147 0.460 0.096 0.161 0.207
CLEC4E 0.017 0.054 0.499 0.029 0.049 0.205
HNRPF −0.007 0.059 0.806 0.039 0.074 0.257
IL18RAP 0.006 0.065 0.843 0.082 0.064 0.018
IL8RB 0.017 0.055 0.495 −0.023 0.075 0.499
KCNE3 0.078 0.080 0.055 0.159 0.299 0.254
KLRC4 0.051 0.098 0.270 0.183 0.168 0.036
NCF4 0.022 0.038 0.227 0.060 0.030 0.002
RPL28 −0.040 0.087 0.326 −0.104 0.101 0.044
S100A12 −0.054 0.080 0.164 −0.051 0.074 0.154
S100A8 −0.021 0.061 0.462 −0.038 0.064 0.208
SLAMF7 0.001 0.082 0.981 0.070 0.092 0.117
SPIB −0.023 0.213 0.812 −0.037 0.201 0.680
TFCP2 −0.011 0.101 0.809 −0.053 0.125 0.356
TLR4 0.072 0.044 0.005 −0.064 0.078 0.095
TMC8 −0.018 0.071 0.579 −0.025 0.132 0.671
TNFAIP6 0.031 0.110 0.540 −0.229 0.150 0.008
TNFRSF10C −0.062 0.274 0.620 −0.285 0.284 0.050
TSPAN16 0.042 0.519 0.858 0.255 0.444 0.221
*p values < 0.05 are in bold.
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fects of temperature and storage period were evaluated
using a clinically validated and commercially available
gene expression assay for the detection of obstructive
coronary artery disease in non-diabetic patients (Corus
CAD) [4]. The GES was derived using Ridge regression
from 640 patients for whom real-time polymerase chain
reaction gene expression data and angiographic data had
been obtained [4]. The GES comprises expression values
for 23 genes from peripheral blood cells in 6 terms as
well as patient age and sex. Each term is composed of
ratios of highly correlated genes representing a diverse
set of inflammatory cell biology, including neutrophil
apoptosis, neutrophil-to-lymphocyte ratio, and natural
killer-cell activation.
The integrity of RNA obtained from RSM was rela-
tively insensitive to elevated temperature or extended
storage, showing a slight decrease in RIN values com-
pared to the baseline arm. Compared to RNA obtained
from the PAXgene control arm, RIN from RSM scores
Figure 4 Correlation of GES and expression levels of underlying 23 genes between RSM and PAXgene under baseline condition. (A)
GES for 25 subjects computed on RNA obtained from RSM (y axis) vs. PAXgene (x axis). (B) Pearson correlation values (r) derived by comparing
RSM to PAXgene (y axis) vs. Cp values (x axis); dashed line denotes r value of 0.9.
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cut-off (RIN >5) for most RNA-based applications
[18,19]. In support of this finding, mean gene expression
values and calculated GES derived from the expression
levels of the genes were highly correlated between RSM
and PAXgene tubes in the baseline arm. PAXgene sam-
ples stored at elevated temperature or for a prolonged
period showed less consistent results, similar to other
published reports [20]. RNA obtained from tubes stored
for 6 days at room temperature showed significantly
lower RIN scores compared to RSM, while PAXgene
samples stored at 37°C yielded higher RIN values but
RNA yield from these tubes was much lower than base-
line (data not shown). At the single-gene level, the ex-
pression of a relatively small number of genes was
significantly affected by either temperature or storage
time on RSM (Table 1; Figure 3A). However, the globalshift in gene expression was more pronounced in RNA
obtained from PAXgene samples at 37°C or 6-day stor-
age, indicating an increased sensitivity to temperature
and time compared to RSM.
Relative to the baseline study, 18 genes showed high
correlation in both elevated time and temperature arms,
with five genes demonstrating lower correlations (r < 0.9,
Figure 3B, C). These lower correlations may be driven
in part by lower overall biological variability in the expres-
sion levels of these genes [16]. Notably, these specific
genes also showed lower correlation with PAXgene-
derived expression levels (Figure 4B). However, from a
global perspective, the calculated GES displayed good
correlation between RSM and PAXgene derived RNA
(r = 0.948, p < 0.001; Figure 4A), demonstrating that
RSM could feasibly be used for such a diagnostic test
with minimal adjustment to the GES.
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signatures for the detection of disease have recently been
developed [4,5,21]. An integral part in the development
and clinical use of such tests is the ability to reprodu-
cibly obtain high quality RNA. To this end, a number of
tube-based methods containing RNA-preservative solu-
tions have been successfully employed [8,9]. Tube-based
collection methods do however pose a number of limita-
tions. Clinical sites may not have access to a phlebotom-
ist, making sample collection a challenge. In addition,
transport of blood in tubes may require temperature-
controlled environments, which can add substantial
costs. Finally, sample volumes are typically in the milli-
liter range, an amount that may be impractical to obtain
in certain clinical scenarios (e.g. work with neonates or
small animals) [11,12]. Some efforts have been made to
miniaturize collection volumes using PAXgene preserva-
tive, however it is unclear how easily these methods
would translate to wider scale use [11,12,22]. In these
regards, dried blood spot technology such as RSM offers
significant advantages.
This study is not without certain limitations. For
simplicity, whole blood was collected in EDTA tubes
prior to manual application onto the RSM filter paper;
an automated methodology for directly applying blood
onto this matrix needs to be evaluated and developed.
Although RNA derived from RSM was of relatively high
integrity, the performance of such RNA was only evalu-
ated by RT-qPCR, a modality which can tolerate signifi-
cant amounts of RNA degradation especially if small
amplicons are used [23]. Other modalities measuring
gene expression levels such as microarrays or RNAseq
could be more sensitive to RNA integrity but this re-
mains to be determined. Additionally, a limited number
of potential transport and storage conditions were evalu-
ated; further studies will need to be performed if this
media is to be considered as a long-term storage option.
As the bead-based method utilized to purify RNA was
optimized for larger transcripts, we were unable to as-
sess the ability of RSM to stabilize smaller RNA species
such as miRNA; we hope to address this limitation in fu-
ture studies. Finally, RSM was produced in a research en-
vironment. Lot-to-lot reagent variability has been shown
to contribute to variability in gene expression-based tests;
further work needs to be performed on commercial-grade
RSM to evaluate lot-to-lot differences [16].
Conclusions
We have evaluated a dried blood spot matrix optimized
for collecting and preserving high-quality RNA, compar-
ing RNA integrity and gene expression levels relative to
PAXgene blood collection tubes drawn in parallel. We
have demonstrated that comparable results are obtained
between RSM filter paper and PAXgene blood collectiontubes under overnight sample storage conditions, and
RSM performance exceeds PAXgene results with longer-
term room temperature storage. Although the current
study was performed on a relatively small set of healthy
subjects, the results indicate that with further develop-
ment an RSM-like approach may provide an attractive,
dry-state method for obtaining and storing RNA from
whole blood samples. Studies evaluating the perform-
ance of RSM in a larger clinical setting using a refined
collection methodology are warranted, and may provide
additional evidence supporting the use of RSM in real-
world clinical settings.
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Additional file 1: Table S1. MIQE data for the 23 genes used to
generate the GES.
Additional file 2: Figure S1. Experimental flow for 25 subjects used in
the PAXgene vs. RSM comparison (A) and for the 10 PAXgene pool
control samples (B).
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